Cargando…
Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis
OBJECTIVE: Most guidelines recommend the use of nonsteroidal anti-inflammatory drugs (NSAIDs), duloxetine, and tramadol for the nonoperative treatment of osteoarthritis (OA), but the use of them is limited by the tolerability and safety concerns. Lutikizumab is a novel anti–IL-1α/β dual variable dom...
Autores principales: | Cao, Ziqin, Li, Yajia, Wang, Wanchun, Jie, Shuo, Hu, Xuantao, Zhou, Jian, Wu, Tong, Aili, Dilihumaer, Long, Zeling, Li, Yihan, Dou, Pengcheng, Wu, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661137/ https://www.ncbi.nlm.nih.gov/pubmed/33204726 http://dx.doi.org/10.1155/2020/9013283 |
Ejemplares similares
-
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
por: Kloppenburg, Margreet, et al.
Publicado: (2019) -
Mesenchymal Stem Cells: A New Choice for Nonsurgical Treatment of OA? Results from a Bayesian Network Meta-Analysis
por: Cao, Ziqin, et al.
Publicado: (2021) -
Targeting nerve growth factor, a new option for treatment of osteoarthritis: a network meta-analysis of comparative efficacy and safety with traditional drugs
por: Cao, Ziqin, et al.
Publicado: (2020) -
Optimal administration strategies of tranexamic acid to minimize blood loss during spinal surgery: results of a Bayesian network meta-analysis
por: Cao, Ziqin, et al.
Publicado: (2022) -
A causal relationship between childhood obesity and risk of osteoarthritis: results from a two-sample Mendelian randomization analysis
por: Cao, Ziqin, et al.
Publicado: (2022)